Lipid Modification (update): draft full guideline

Please note that this guideline will update and replace recommendations relating to risk assessment and lipids management for type 1 and type 2 diabetes and chronic kidney disease, and statin therapy for people at increased risk of developing cardiovascular disease or those with established cardiovascular disease:

This page was last updated: 10 February 2014